Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Schawbel Group, LLC Takes Exclusive Option on Proprietary Nutrition Formulation

Schawbel Group,LLC
Posted on: 07 Nov 17

Schawbel Group, LLC today announced that it has entered into an exclusive option agreement with Tufts University. The agreement relates to Tufts’ patent pending formulation that can provide the basis for a new generation of food products in the form of a nutritional supplement for the prevention and treatment of moderate acute malnutrition (MAM) focused on enhancing cognitive performance.

Currently, cognitive impairment associated with early childhood malnutrition and stunting is generally considered irreversible. However, a scientist from Tufts University believes that cognitive damage may be reversible for children younger than five with the right nutrition, and that it may have potential for use even in the U.S. where poor dietary habits are common in children. Furthermore, the researchers hope to test the formulation to see if it may be effective for delaying aging-related cognitive decline.

William Schawbel, founder and owner of Schawbel Group, LLC, has been working closely with Susan B. Roberts, PhD. Dr. Roberts is professor at the Friedman School of Nutrition Science and Policy at Tufts and professor of psychiatry at Tufts University School of Medicine. Dr. Roberts has been the Principal Investigator and designed the nutritional formulation and co-designed the products for testing. She supervised intervention trials conducted in Guinea-Bissau. This investigative phase of the project started in 2014 and the series of studies will be completed in December of 2017. The project to date has been funded by Tufts with major contributions from Mr. Schawbel’s family’s philanthropic foundation. He has also provided pro bono consulting services from his company. The formulation used in this research project is the subject of a pending patent application.

Schawbel has contractual rights over a period of time to obtain an exclusive worldwide license to this patent application and the formulation it claims. Schawbel Group will be actively pursuing commercial partners to complete the research and based on positive findings, create a product line and introduce it into the global marketplace.

About Schawbel Group, LLC

Schawbel Group, LLC is a spinoff from The Schawbel Corporation in 2014, a then privately held company that was founded in 1981 and was the inventor of the ThermaCELL line of cordless consumer products. Schawbel Group provides consulting services on all aspects of consumer products and services through its seasoned, globally located consultants. Schawbel provides consulting to commercial clients, philanthropic organizations, and educational institutions.

For more details, visit www.schawbelgroup.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171107005201/en/

Business Wire
www.businesswire.com

Last updated on: 07/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.